G1 Therapeutics Inc (GTHX) Shares Rise Despite Market Challenges
The stock of G1 Therapeutics Inc (NASDAQ: GTHX) has increased by 6.99 when compared to last closing price of 4.29. Despite this, the company has
The stock of G1 Therapeutics Inc (NASDAQ: GTHX) has increased by 6.99 when compared to last closing price of 4.29. Despite this, the company has
GTHX has 36-month beta value of 1.70. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,”
The stock of G1 Therapeutics Inc (GTHX) has seen a -12.85% decrease in the past week, with a 48.57% gain in the past month, and
The stock of G1 Therapeutics Inc (GTHX) has gone up by 7.83% for the week, with a -23.83% drop in the past month and a
G1 Therapeutics Inc (NASDAQ: GTHX) has seen a rise in its stock price by 14.59 in relation to its previous close of 2.40. However, the
The 36-month beta value for GTHX is also noteworthy at 1.71. The public float for GTHX is 42.75M, and at present, short sellers hold a
The stock of G1 Therapeutics Inc (GTHX) has seen a -54.57% decrease in the past week, with a -33.28% drop in the past month, and
Moreover, the 36-month beta value for GTHX is 1.77. The public float for GTHX is 42.75M and currently, short sellers hold a 7.61% of that
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.